The 10-second takeaway
For the quarter ended May 4 (Q1), Genesco missed estimates on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue shrank slightly. Non-GAAP earnings per share dropped. GAAP earnings per share shrank.
Gross margins dropped, operating margins grew, net margins dropped.
Genesco reported revenue of $591.4 million. The nine analysts polled by S&P Capital IQ predicted revenue of $604.4 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.94. The nine earnings estimates compiled by S&P Capital IQ forecast $0.85 per share. Non-GAAP EPS of $0.94 for Q1 were 4.1% lower than the prior-year quarter's $0.98 per share. (The prior-year quarter included -$0.01 per share in earnings from discontinued operations.) GAAP EPS of $0.78 for Q1 were 8.2% lower than the prior-year quarter's $0.85 per share. (The prior-year quarter included -$0.01 per share in earnings from discontinued operations.)
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 50.5%, 100 basis points worse than the prior-year quarter. Operating margin was 6.2%, 20 basis points better than the prior-year quarter. Net margin was 3.1%, 30 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $605.3 million. On the bottom line, the average EPS estimate is $0.58.
Next year's average estimate for revenue is $2.73 billion. The average EPS estimate is $5.63.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 117 members out of 133 rating the stock outperform, and 16 members rating it underperform. Among 40 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 38 give Genesco a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Genesco is buy, with an average price target of $72.88.
Is Genesco the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.
- Add Genesco to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.